Onassis Holdings Corp. announced its entry into the rejuvenation therapy market with a epigenetic programming technology. Through an exclusive perpetual license agreement with a leading Israeli university, Onassis Holdings will have the right to develop, manufacture, market, distribute, and sell products utilizing this cutting-edge technology worldwide.